Referencias
Abeloff, M. D., Armitage, J. O., Lichter, A. S. y Niederhuber, J. E.
(Eds.). (2000). Clinical Oncology (2.ª ed.). Nueva York: Churchill Livingstone.
Ahles, T., Saykin, A., Furstenberg, C. et al. (2002). Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. Journal of Clinical Oncology, 20(2), 485-493.
Albright, A. y Valente, S. (1998). Depression and suicide. En R. Carroll-Johnson et al. (Ed.), Psychosocial nursing care along the cancer continuum (pp. 153-165). Pittsburgh, PA: Oncology Nursing Press.
American Cancer Society: Sexuality and cancer for the woman who has cancer and her partner. (2001) Publicación N.º 4657.
American Cancer Society: Sexuality and cancer for the man who has cancer and his partner. (2001) Publicación N.º 4658.
Berg, D. (2001). Diarrhea. En J. M. Yasko (Ed.), Nursing Management of Symptoms Associated with Chemotherapy (5.ª ed., pp. 109-130). West Conshohocken, PA: Menicus Health Care Communication.
Boyle, D. (2001). Psychosocial issues. En E. Lin (Ed.), Advanced practice in oncology nursing (pp. 213-232). Filadelfia: WB Saunders.
Brietbart, W. (2002). Depression. En K. Kuebler y P. Esper (Eds.), Palliative practice from a-z (pp. 85-88). Pittsburgh, PA: Oncology Nursing Press Press.
Briscoe, K. (1989). Optimal management of nausea and vomiting in clinical oncology. Oncology, 3 (Suplemento 8), 11-15.
Carroll-Johnson, R. M., Gorman, L. M. y Bush, N. J. (Eds.). (1998). Anxiety and the cancer experience. Pittsburgh, PA: Oncology Nursing Press.
The Cleveland Clinic Foundation. For your information: home instructions for management of nausea. (1995).
Conrad K.J. (2001). Cutaneous reactions. En Yasko J.M. (Ed.), Nursing Management of Symptoms Associated with Chemotherapy (5.ª ed.).
Constipation protocol. (1995). Cleveland Clinic Foundation: Triage protocols for the oncology nurse help line program.
Cope, D. (2001). Exploring the relationship between cognitive function and chemotherapy. Clinical Journal of Oncology Nursing, 5(5), 233-234.
Costabel, U. y King, T. E. (2001). International consensus statement on idiopathic pulmonary fibrosis. European Respiratory Journal, 17(2), 163-167.
Couillard-Getreuer D.L. y Lutgen Heery M. (1994). Protective mechanisms: skin. En Gross J. y Libey Johnson B. (Eds.), Handbook of Oncology Nursing (2.ª ed., pp. 421-463). Boston, MA: Jones & Bartlett.
Fabian, C.J., Molina, R. y Slavik, M. (1990). Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion. Investigational New Drugs, 8(1), 57-63.
Información sobre la salud. (2002). Obtenida el 9 de mayo de 2003, en http://www.nei.nih.gov/health/index.htm" target=_new>http://www.nei.nih.gov/health/index.htm
Gacsedi, R.A. (2002). Massage therapy for patients with cancer. Clinical Journal of Oncology Nursing, 6(1), 52-54.
Gordon, K.B., Tajuddin, A. y Guitart, J. (1995). Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy. Cancer, 75(8), 2169-2173.
Gross, J. y Johnson, B.L. (Eds.). (1998). Handbook of oncology nursing. Londres: Jones and Bartlett Publishers International Publications.
Harsch, R. (2002). Preventing infection during your chemotherapy treatment. Georgia-Pacific health smart institute association for professionals in infection control and epidemiology.
Hoffman, R., Benz, E.J., Shattil, S.J., Furie, B., Cohen, H.J., Silberstein, L.E. et al. (Eds.). (2000). Hematology: basic principles and practice, 3.ª edición. Nueva York: Churchill Livingstone.
Hussein M.A., Wood L., Saluan M.A. et al. (1998). Efficacy of pyridoxine to ameliorate cutaneous toxicity associated with doxil, resumen N.º 4143. Documento presentado en la Sociedad Estadounidense de Hematología (American Society of Hematology).
Información sobre el producto ImmuCyst®. (2002). Obtenida el 8 de mayo de 2003, en http://www.immucyst.com/product.html" target=_new>http://www.immucyst.com/product.html
Itano, J. y Taoka, K. (Eds.). (1998). Core curriculum for oncology nursing (3.ª ed.). Filadelfia, PA: W.B Saunders Co.
Karlowicz, K. (Ed.). (1995). Urologic nursing; principles and practice. Filadelfia, PA: WB Saunders Co.
King, T.E. et al. (2000). Idiopathic pulmonary fibrosis: diagnosis and treatment. Declaración de consenso internacional. Sociedad Americana de Tórax (American Thoracic Society, ATS) y Sociedad Europea de Enfermedades Respiratorias (European Respiratory Society, ERS). American Journal of respiratory critical care medicine, 161(2), 646-664.
Lee A. y Thomson J. (1999). Drug-induced skin reactions. Pharmaceutical Journal, 262, 357-362.
Lexi-Drugs online. (2002, 3/18/03). Obtenido el 5 de mayo de 2003, en http://www.crlonline.com/" target=_new>http://www.crlonline.com
Living with glaucoma. (2002). Obtenido el 9 de mayo de 2003, en http://www.glaucoma.org/" target=_new>http://www.glaucoma.org/
Lubejko, B.G. y Sartorius, S.E. (1993). Nursing considerations in paclitaxel (Taxol®) administration. Seminars in Oncology, 20 (4, Suplemento 3), 26-30.
Lynch, M.P. (2000). Depression in the cancer patient. Nurse Practioner SIG(Nov.), 4-5.
Malpas, J., Bergsagel, D. y Kyle, A. (Eds.). (1998). Myeloma biology and management (2.ª ed.). Nueva York: Oxford University Press.
MD Consult: A resource for clinicians. (2003, 1/2/2003). Obtenido el 8 de mayo de 2003, en http://home.mdconsult.com/" target=_new>http://home.mdconsult.com
Meek, P.M. et al. (1999). Dyspnea. Mechanisms, assessment and management: a consensus statement. Sociedad Américana de Tórax (American Thoracic Society). American Journal of respiratory critical care medicine, 159(1), 321-340.
Mellors, R.C. (8/27/2002). Immunopathology; hypersensitivity reactions. Obtenido el 8 de mayo de 2003, en http://edcenter.med.cornell.edu/CUMC_PathNotes/Immunopathology/Immuno_02.html" target=_new>http://edcenter.med.cornell.edu/CUMC_PathNotes/Immunopathology/Immuno_02.html
Merideth, P.V. y Horan, N.M. (Eds.). (2000). Adult primary care. Filadelfia: WB Saunders Co.
Mortimer J. y Anderson I. (1990). Weekly fluorouracil and high-dose leucovorin: efficacy and treatment of cutaneous toxicity. Cancer Chemotherapy and Pharmacology, 26, 449-452.
Mosby's GenRx. (2001, 1/2/2003). Obtenido el 8 de mayo de 2003, en http://home.mdconsult.com/" target=_new>http://home.mdconsult.com
Our bodies, ourselves for the new century: A book by and for women (Comprehensive book on women's health and sexuality) Boston Women's Health Book Collective. (1998). Nueva York: Touchstone Books.
PEG-INTRON®
(peginterferon alfa-2b) Powder for Injection. (2002). Obtenido el 9 de mayo de 2003, en http://www.pegintron.com/" target=_new>http://www.pegintron.com/
Pike, K. (2001). Hand-foot syndrome. Oncology Nursing Forum, 28(10), 1519-1520.
Pisarnthanarax, N. y Duvic M. (2002). Dermatologic complications of cancer chemotherapy. En J.F. Holland y E. Frei (Eds.), Cancer Medicine (pp. 2271-2278). Hamilton, Ontario: BC Decker Inc.
P.M. Meek et al. (1999). Dyspnea: mechanisms, assessment and management: a consensus statement American Thoracic Society. American Journal of Respiratory Critical Care Medicine, 159(1), 321-340.
Preparing for your treatment with BEXXAR® : A patient's guide to the BEXXAR® therapeutic regimen for non-Hodgkin's lymphoma, folleto para el paciente. (2003). The GlaxoSmithKline Group of Companies y Corixa Corporation.
Questions and Answers About Taxotere®for Injection Concentrate. (2002). Obtenido el 9 de mayo de 2003, en http://www.aventis-us.com/PIs/taxotere_pat_info_TXT.html" target=_new>http://www.aventis-us.com/PIs/taxotere_pat_info_TXT.html
Recommendations for the use of antiemetics. (2002, 2002). Obtenido el 9 de mayo de 2003, en http://www.asco.org/ac/1,1003,_12-002032-00_18-0010772-00_19-0010774-00_20-001,00.asp" target=_new>http://www.asco.org/ac/1,1003,_12-002032-00_18-0010772-00_19-0010774-00_20-001,00.asp
Seller, R. (Ed.). (2000). Differential diagnosis of common complaints. Filadelfia: WB Saunders Co.
Schover, L. R. (1997). Sexuality and fertility after cancer. Nueva York: John Wiley & Sons.
Schwartz, S. y Plawecki, H. (2002). Consequences of chemotherapy on the sexuality of patients with lung cancer. Clinical Journal of Oncology Nursing, 6(4).
Self Help for Hard of Hearing People. (2002, 4/11/03). Obtenido el 9 de mayo de 2003, en http://www.shhh.org/" target=_new>http://www.shhh.org
Shelton, B.K. y Turnbough, L. (1996). Flu-like syndrome. En S. Groenwald (Ed.), Cancer Symptom Management (pp. 59-71). Boston, MA: Jones and Bartlett.
Sherry V.W. (2001). Taste alterations among patients with cancer. Clinical Journal of Oncology Nursing, 6(2), 73-77.
Skeel, R. (Ed.). (1999). Handbook of cancer chemotherapy. Filadelfia: Lippincott, Williams & Wilkins.
Specific Information for the Health Professional. (2003, 7 de mayo de 2003). Obtenido el 8 de mayo de 2003, en http://www.atsdr.cdc.gov/" target=_new>http://www.atsdr.cdc.gov
Spencer, P. (2002). Anxiety. En K. Kuebler y P. Esper (Eds.), Palliative practice from a-z (pp. 23-26). Pittsburgh, PA: ONS Press.
St Marie, B. (2000). Anxiety. En D. H. Camp-Sorrell, R, (Ed.), Clinical manual for the oncology practice nurse (pp. 133-134). Pittsburgh, PA: ONS Press.
Stoller, J.K., Ahmad, M. y Longworth, D.L. (Eds.). (2002). Intensive review of internal medicine (3.ª ed.). Filadelfia, PA: Lippincott, Williams and Wilkins.
Tierney, L.M., McPhee, S.J. y Papadakis, M.A. (Eds.). (2001). Current medical diagnosis and treatment (40.ª ed.). Stanford, CT: Appleton and Lange.
Triozzi, P. y Laszlo, J. (1990). Recent advances in the control of nausea and vomiting. Primary Care & Cancer.
Uphold, C.R. y Graham, M.V. (Eds.). (1999). Clinical guidelines in adult health (5.ª ed.). Gainesville, FL: Barmarrae Books.
USPHS/IDSA Guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary. (1995). MMWR, 44, RR-8.
Uthman, E.O. (1996, 9/16/2001). Interpretation of lab test profiles. Obtenido el 8 de mayo de 2003, en http://mededucation.bjmu.edu.cn/Lab%20Test%20Interpretation.htm" target=_new>http://mededucation.bjmu.edu.cn/Lab%20Test%20Interpretation.htm
Viale, P. y Mister, S. (2001). Utilization of medical-assistance programs for medically uninsured patients: one public teaching hospital's experience. Clinical Journal of Oncology Nursing, 5(6), 247-252.
Voss, M.A.B. y Wilkes, G.M. (1999). Neurotoxicities. American Journal of Nursing, Oncology Nursing Update, 20-23.
Weihofen, D. y Marino, C. (1998). The cancer survival cookbook. Nueva York: John Wiley & Sons.
Weiss P.A. y O'Rourke M. (1999). Cutaneous manifestations of cancer and cancer treatment. American Journal of Nursing (Suplemento de abril), 13-16.
Wilkes, G.M. (1996). Neurological disturbances. En S. Groenwald (Ed.), Cancer Symptom Management (pp. 323-330). Boston, MA: Jones and Bartlett.
Wilkes, G.M., Ingwersen y Barton-Burke (Eds.). (2002). Oncology Nursing Drug Handbook. Boston, MA: Jones and Bartlett.
Wilkinson, K. (2001). Irinotecan hydrochloride. Clinical Journal of Oncology Nursing, 5(4), 179.
Woodruff, R. (1997). Gastrointestinal. En Pharmacia & Upjohn (Eds.), Symptom control in advanced cancer (pp. 18-21). Melbourne.
Yarbro, C.H., Frogge, M.H., Goodman, M. y Groenwald, S.L. (Ed.). (1999). Cancer symptom management (5.ª ed.). Boston, MA: Jones and Barlett.
Zilbergeld, B. (1999). The new male sexuality: The truth about men, sex and pleasure. Nueva York: Bantam Books.
